Literature DB >> 33556139

Abnormal neuroinflammation in fibromyalgia and CRPS using [11C]-(R)-PK11195 PET.

Seongho Seo1, Ye-Ha Jung2, Dasom Lee2, Won Joon Lee3, Joon Hwan Jang2,4, Jae-Yeon Lee2, Soo-Hee Choi5, Jee Youn Moon6, Jae Sung Lee7,8,9, Gi Jeong Cheon8,9, Do-Hyung Kang10.   

Abstract

PURPOSE: Fibromyalgia (FM) and complex regional pain syndrome (CRPS) share many pathological mechanisms related to chronic pain and neuroinflammation, which may contribute to the multifactorial pathological mechanisms in both FM and CRPS. The aim of this study was to assess neuroinflammation in FM patients compared with that in patients with CRPS and healthy controls.
METHODS: Neuroinflammation was measured as the distribution volume ratio (DVR) of [11C]-(R)-PK11195 positron emission tomography (PET) in 12 FM patients, 11 patients with CRPS and 15 healthy controls.
RESULTS: Neuroinflammation in FM patients was significantly higher in the left pre (primary motor cortex) and post (primary somatosensory cortex) central gyri (p < 0.001), right postcentral gyrus (p < 0.005), left superior parietal and superior frontal gyri (p < 0.005), left precuneus (p < 0.01), and left medial frontal gyrus (p = 0.036) compared with healthy controls. Furthermore, the DVR of [11C]-(R)-PK11195 in FM patients demonstrated decreased neuroinflammation in the medulla (p < 0.005), left superior temporal gyrus (p < 0.005), and left amygdala (p = 0.020) compared with healthy controls.
CONCLUSIONS: To the authors' knowledge, this report is the first to describe abnormal neuroinflammation levels in the brains of FM patients compared with that in patients with CRPS using [11C]-(R)-PK11195 PET. The results suggested that abnormal neuroinflammation can be an important pathological factor in FM. In addition, the identification of common and different critical regions related to abnormal neuroinflammation in FM, compared with patients with CRPS and healthy controls, may contribute to improved diagnosis and the development of effective medical treatment for patients with FM.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33556139      PMCID: PMC7870009          DOI: 10.1371/journal.pone.0246152

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  44 in total

Review 1.  The cortical representation of pain.

Authors:  R D Treede; D R Kenshalo; R H Gracely; A K Jones
Journal:  Pain       Date:  1999-02       Impact factor: 6.961

Review 2.  Organization of peripheral and central pain pathways.

Authors:  J R Bloedel; D B McCreery
Journal:  Surg Neurol       Date:  1975-07

Review 3.  Brain imaging in fibromyalgia syndrome.

Authors:  R Staud
Journal:  Clin Exp Rheumatol       Date:  2012-01-03       Impact factor: 4.473

4.  Development of the stress response inventory and its application in clinical practice.

Authors:  K B Koh; J K Park; C H Kim; S Cho
Journal:  Psychosom Med       Date:  2001 Jul-Aug       Impact factor: 4.312

5.  Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation.

Authors:  J Lorenz; S Minoshima; K L Casey
Journal:  Brain       Date:  2003-05       Impact factor: 13.501

6.  Antinociception by motor cortex stimulation in the neuropathic rat: does the locus coeruleus play a role?

Authors:  Hanna Viisanen; Antti Pertovaara
Journal:  Exp Brain Res       Date:  2009-10-14       Impact factor: 1.972

Review 7.  Neurobiology of fibromyalgia and chronic widespread pain.

Authors:  Kathleen A Sluka; Daniel J Clauw
Journal:  Neuroscience       Date:  2016-06-09       Impact factor: 3.590

8.  Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia.

Authors:  Markus Burgmer; Markus Gaubitz; Carsten Konrad; Marco Wrenger; Sebastian Hilgart; Gereon Heuft; Bettina Pfleiderer
Journal:  Psychosom Med       Date:  2009-05-04       Impact factor: 4.312

Review 9.  The Role of Cannabinoid Receptors in the Descending Modulation of Pain.

Authors:  Enza Palazzo; Livio Luongo; Vito de Novellis; Francesco Rossi; Sabatino Maione
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-16

10.  [11C]-(R)-PK11195 positron emission tomography in patients with complex regional pain syndrome: A pilot study.

Authors:  So Yeon Jeon; Seongho Seo; Jae Sung Lee; Soo-Hee Choi; Do-Hyeong Lee; Ye-Ha Jung; Man-Kyu Song; Kyung-Jun Lee; Yong Chul Kim; Hyun Woo Kwon; Hyung-Jun Im; Dong Soo Lee; Gi Jeong Cheon; Do-Hyung Kang
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

View more
  5 in total

Review 1.  Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica.

Authors:  Kornelis S M van der Geest; Maria Sandovici; Pieter H Nienhuis; Riemer H J A Slart; Peter Heeringa; Elisabeth Brouwer; William F Jiemy
Journal:  Front Med (Lausanne)       Date:  2022-06-06

2.  Inflammation and Interferon Signatures in Peripheral B-Lymphocytes and Sera of Individuals With Fibromyalgia.

Authors:  Serena Fineschi; Joakim Klar; Kristin Ayoola Gustafsson; Kent Jonsson; Bo Karlsson; Niklas Dahl
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 3.  The Role of Neuro-Immune Interactions in Chronic Pain: Implications for Clinical Practice.

Authors:  Po-Yi Paul Su; Lingyi Zhang; Liangliang He; Na Zhao; Zhonghui Guan
Journal:  J Pain Res       Date:  2022-08-04       Impact factor: 2.832

4.  A behavioral and brain imaging dataset with focus on emotion regulation of women with fibromyalgia.

Authors:  Thania Balducci; Jalil Rasgado-Toledo; Alely Valencia; Marie-José van Tol; André Aleman; Eduardo A Garza-Villarreal
Journal:  Sci Data       Date:  2022-09-22       Impact factor: 8.501

5.  Altered basal ganglia infraslow oscillation and resting functional connectivity in complex regional pain syndrome.

Authors:  Barbara Lee; Flavia Di Pietro; Luke A Henderson; Paul J Austin
Journal:  J Neurosci Res       Date:  2022-04-20       Impact factor: 4.433

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.